<DOC>
	<DOCNO>NCT02920372</DOCNO>
	<brief_summary>The study consist generation biological sample ( blood urine ) positive Epoetin alfa laboratory wish perform analysis dope control maintain accreditation World Anti-Doping Agency .</brief_summary>
	<brief_title>Generation Positive Biological Samples Epoetin Doping Control .</brief_title>
	<detailed_description />
	<mesh_term>Epoetin Alfa</mesh_term>
	<criteria>1 . Healthy male volunteer age 18 50 year . 2 . A health profile devoid organic physiological disorder . 3 . The ECG general blood urine laboratory test perform study within normal range . Minor occasional change normal range accept , investigator 's opinion , consider current state art , clinically significant , lifethreatening subject interfere product assessment . These change nonrelevance justify write specifically . 4 . Body mass index ( BMI=weigh/height2 ) range 19 27 Kg/m2 weight 50 110 kg . 5 . Understanding accept study procedure sign informed consent form . 1 . Non compliance inclusion criterion . 2 . Having suffer organic disease major surgery three month prior start study . 3 . A prior history presence significant cardiovascular , neurological , haematological , psychiatric , hepatic , gastrointestinal , pulmonary , endocrine , immunologic renal disease , investigator 's opinion , consider current state art , clinically significant , lifethreatening subject could interfere product assessment ; may lead suspect disorder drug absorption , distribution , metabolism excretion , suggest gastrointestinal irritation due drug . 4 . History clinical evidence psychiatric disorder , alcoholism , drug abuse , regular use psychoactive drug . 5 . History hypertension , seizure , endocrine disorder ( diabetes hypothyroidism ) , coagulation disorder , kidney and/or liver disease . 6 . Subjects drug involve study counter indicate . 7 . Smokers 20 cigarette per day . 8 . Taking 35 g alcohol per day . 9 . Drinking 5 drink contain xanthine per day . 10 . Regular use drug month prior study session . The treatment single limited dos symptomatic medicinal product week prior study session reason exclusion calculate cleared completely day experimental session . 11 . Have take part study blood donation last 8 week prior start study . 12 . History allergy , idiosyncrasy , hypersensitivity adverse reaction active substance excipients . 13 . Have volunteer another study drug last 3 month prior start study . 14 . Subjects positive serology hepatitis B , C HIV . 15 . Subjects unable understand nature , consequence study procedure request follow .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>